Sparsentan

CAS 254740-64-2

Overview

Sparsentan is an FDA-approved medication used to treat primary immunoglobulin A nephropathy (IgAN) to help maintain kidney function and reduce protein in urine (proteinuria)

Anant Labs manufacture and furnish high quality Sparsentan impurities for global markets. Our Sparsentan EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

In Stock

Sparsentan

CAS 254740-64-2In Stock

Technical Data

CAS254740-64-2

Mol. FormulaC₃₂H₄₀N₄O₅S

Mol. Weight592.762 g/mol

IUPAC2-[4-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2-(ethoxymethyl)phenyl]-N-(4,5-dimethyl-1,2-oxazol-3-yl)benzenesulfonamide

SMILESCCCCC1=NC2(CCCC2)C(=O)N1CC3=CC(=C(C=C3)C4=CC=CC=C4S(=O)(=O)NC5=NOC(=C5C)C)COCC

InChIInChI=1S/C32H40N4O5S/c1-5-7-14-29-33-32(17-10-11-18-32)31(37)36(29)20-24-15-16-26(25(19-24)21-40-6-2)27-12-8-9-13-28(27)42(38,39)35-30-22(3)23(4)41-34-30/h8-9,12-13,15-16,19H,5-7,10-11,14,17-18,20-21H2,1-4H3,(H,34,35)

InChI KeyWRFHGDPIDHPWIQ-UHFFFAOYSA-N

Note: We are upgrading our system, Cat No will change.

Synonyms

sparsentan254740-64-2RE-021FILSPARIPS433540esparsentanPS-433540sparsentanum9242RO5URM(1,1'-Biphenyl)-2-sulfonamide, 4'-((2-butyl-4-oxo-1,3-diazaspiro(4.4)non-1-en-3-yl)methyl)-N-(4,5-dimethyl-3-isoxazolyl)-2'-(ethoxymethyl)-

Impurities (1)

Impurity

Sparsentan (In-House)

Cat. No.: ANT-SPR-000

In StockRFQ

Sparsentan

Sparsentan

Impurities (1)

Sparsentan (In-House)

Looking for a specific reference standard?